Cargando…
Exploring the kinetic selectivity of drugs targeting the β(1)‐adrenoceptor
In this study, we report the β(1)‐adrenoceptor binding kinetics of several clinically relevant β(1/2)‐adrenoceptor (β(1/2)AR) agonists and antagonists. [(3)H]‐DHA was used to label CHO‐β(1)AR for binding studies. The kinetics of ligand binding was assessed using a competition association binding met...
Autores principales: | Sykes, David A., Jiménez‐Rosés, Mireia, Reilly, John, Fairhurst, Robin A., Charlton, Steven J., Veprintsev, Dmitry B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237807/ https://www.ncbi.nlm.nih.gov/pubmed/35762357 http://dx.doi.org/10.1002/prp2.978 |
Ejemplares similares
-
Combined docking and machine learning identify key molecular determinants of ligand pharmacological activity on β2 adrenoceptor
por: Jiménez‐Rosés, Mireia, et al.
Publicado: (2022) -
Functional solubilization of the β(2)-adrenoceptor using diisobutylene maleic acid
por: Harwood, Clare.R., et al.
Publicado: (2021) -
Functional desensitization of the β(2) adrenoceptor is not dependent on agonist efficacy
por: Rosethorne, Elizabeth M, et al.
Publicado: (2015) -
Are Selective Beta-Adrenoceptor Blocking Drugs an Advantage?
por: Kendall, M.J.
Publicado: (1981) -
A Selective Pharmacophore Model for β(2)-Adrenoceptor Agonists
por: Xing, Rui-Juan, et al.
Publicado: (2009)